From Name

From Email

To Name

To Email

Message

Pivotal study launches exploring novel device for women with OAB

from Urology Times

Pivotal study launches exploring novel device for women with OAB Urology Times The OverActive Bladder Stimulation System Study (OASIS) has launched, aiming to establish the safety and efficacy of the RENOVA iStim implantable tibial neuromodulation system for the treatment of women with overactive bladder (OAB). The multicenter, open-label, prospective, interventional OASIS trial (NCT03596671) is specifically examining the capability of RENOVA to reduce urinary urgency incontinence (UUI) episodes. The study, which has an enrollment goal of 200 patients, is recruiting patients at 15 sites in the United States and Europe. READ MORE

more